These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9566672)

  • 21. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of serum levels of cytokines and intercellular adhesion molecule-1 (ICAM-1) in astrocytic tumours.
    Nano R; Capelli E; Argentina F; Facoetti A; Gerzeli G
    Cell Mol Biol (Noisy-le-grand); 2003 Jun; 49(4):525-8. PubMed ID: 12899444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
    Steen VD; Engel EE; Charley MR; Medsger TA
    J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1.
    Andersen GN; Caidahl K; Kazzam E; Petersson AS; Waldenström A; Mincheva-Nilsson L; Rantapää-Dahlqvist S
    Arthritis Rheum; 2000 May; 43(5):1085-93. PubMed ID: 10817563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
    Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating interleukin 1 beta and soluble interleukin 2 receptor: evaluation as markers of disease activity in scleroderma.
    Patrick MR; Kirkham BW; Graham M; Harrision LC
    J Rheumatol; 1995 Apr; 22(4):654-8. PubMed ID: 7791158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients.
    Klein B; Levin I; Kfir B; Mishaeli M; Shapira J; Klein T
    Tumour Biol; 1995; 16(5):290-6. PubMed ID: 7652467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival.
    Christiansen I; Enblad G; Kälkner KM; Gidlöf C; Glimelius B; Tötterman TH
    Leuk Lymphoma; 1995 Oct; 19(3-4):243-51. PubMed ID: 8535215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of interleukins 2, 6 and 8, soluble interleukin-2 receptor and intercellular adhesion molecule-1 during treatment with interleukin-2 plus interferon-alfa.
    Vuoristo MS; Kellokumpu-Lehtinen P; Laine S; Soppi E
    Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):337-54. PubMed ID: 8872489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble immunological parameters and early prognosis of renal cell cancer patients.
    Kallio JP; Tammela TL; Marttinen AT; Kellokumpu-Lehtinen PL
    J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
    De Rie MA; Zonneveld IM; Witkamp L; Van Lier RA; Out TA; Bos JD
    Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
    Uchio E; Matsumoto T; Tanaka SI; Ohno S
    Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.
    Correia O; Delgado L; Roujeau JC; Le Cleach L; Fleming-Torrinha JA
    Arch Dermatol; 2002 Jan; 138(1):29-32. PubMed ID: 11790164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations.
    Degiannis D; Seibold JR; Czarnecki M; Raskova J; Raska K
    Arthritis Rheum; 1990 Mar; 33(3):375-80. PubMed ID: 2317223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The level of soluble forms of interleukin-2 receptor and adhesive molecules ICAM-1 and VCAM-1 in platelets of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Pol Merkur Lekarski; 1999 Jan; 6(31):23-6. PubMed ID: 10344149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating intercellular adhesion molecule 1 in rheumatoid arthritis--relationship to systemic vasculitis and microvascular injury in nailfold capillary microscopy.
    Kuryliszyn-Moskal A; Bernacka K; Klimiuk PA
    Clin Rheumatol; 1996 Jul; 15(4):367-73. PubMed ID: 8853170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
    Parasole R; Izzo F; Perrone F; Pignata S; Galati MG; Leonardi E; Castiglione F; Orlando R; Castello G; Esposito G; Gallo C; Daniele B
    Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Levels of soluble intracellular adhesion molecules 1 (sICAM-1) , soluble receptors for interleukin 2 (sIL-2R) and anti-Epstein-Barr viral capsid antigen (anti-VCA IgM) in blood serum during the course of infectious mononucleosis].
    Tomasiewicz K; Modrzewska R; Łyczak A; Lis J
    Wiad Lek; 2001; 54(3-4):171-8. PubMed ID: 11436683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentoxyfilline treatment does not influence the plasma levels of IL-2 and sIL-2R in limited scleroderma patients.
    Chibowska M; Krasowska D; Weglarz J
    Med Sci Monit; 2001; 7(2):282-8. PubMed ID: 11257736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.